U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

Columnist Leigh Anne Nelson rethinks her MS medication, discovering a risk and navigating crucial treatment decisions with ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop it in its tracks.

B-cell therapy (also called B-cell depletion therapy) is a treatment for people with multiple sclerosis (MS). Learn what you need to know about this option.

New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies.

Most treatments for multiple sclerosis (MS) focus on a type of white blood cell called T cells. But a newer form of treatment focuses on a different form of white blood cell called B cells. They ...

T cells are the immune system’s frontline fighters. When they detect danger, they rapidly multiply and transform into ...

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, ...

Researchers at Washington University School of Medicine in St. Louis have shown that the cancer therapy known as CAR-T can be applied to multiple sclerosis (MS), an autoimmune disease of the ...

Natural killer cells from multiple sclerosis patients in remission have properties resembling those of NK type 2 cells, which can favour functional deviation of T cells toward Th2 and prohibit ...